Pfizer Financial Ratios
NYSE: PFEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Pfizer ratio analysis
Pfizer earned a net margin of 12.4% in FY 2025, down from 12.6% a year earlier. Gross margin was 74.3% compared with a median of 76.7% over the prior 9 years. Return on equity reached 9.0%, meaning Pfizer generated 0.09 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.75 versus 0.73 the year before, and the current ratio was 1.16. At the end of FY 2025, PFE traded at 18.5 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 9.4 to 77.8, with a median of 18.7. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Pfizer financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 18.51 | 18.86 | 77.81 | 9.37 | 15.34 | 22.58 | 13.10 | 21.82 | 9.76 | 26.34 |
| Price / sales | 2.29 | 2.37 | 2.73 | 2.84 | 4.07 | 4.91 | 5.03 | 5.87 | 3.90 | 3.55 |
| Price / book | 1.65 | 1.71 | 1.83 | 3.00 | 4.28 | 3.23 | 3.26 | 3.78 | 2.88 | 3.15 |
| Gross margin | 74.3% | 71.9% | 58.1% | 66.1% | 62.1% | 79.6% | 80.3% | 78.0% | 78.6% | 76.7% |
| Net margin | 12.4% | 12.6% | 3.6% | 31.0% | 27.0% | 22.0% | 39.2% | 27.3% | 40.6% | 13.7% |
| Free cash flow margin | 14.5% | 15.5% | 8.0% | 25.7% | 36.7% | 29.2% | 25.8% | 33.9% | 28.3% | 27.2% |
| Return on equity (ROE) | 9.0% | 9.1% | 2.4% | 32.8% | 28.5% | 14.5% | 25.4% | 17.6% | 29.9% | 12.1% |
| Return on assets (ROA) | 3.7% | 3.8% | 0.9% | 15.9% | 12.1% | 5.9% | 9.6% | 7.0% | 12.4% | 4.2% |
| Debt / equity | 0.75 | 0.73 | 0.81 | 0.37 | 0.50 | 0.63 | 0.83 | 0.66 | 0.61 | 0.71 |
| Current ratio | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 | 1.35 | 0.88 | 1.57 | 1.35 | 1.25 |
| Revenue growth | -1.6% | 6.8% | -41.1% | 24.5% | 95.2% | 1.8% | 0.2% | -22.3% | -0.5% | 8.1% |
| EPS growth | -3.5% | 281.1% | -93.2% | 42.1% | 136.2% | -42.2% | 50.8% | -46.9% | 200.9% | 5.4% |